<DOC>
	<DOCNO>NCT00543595</DOCNO>
	<brief_summary>This study test safety effectiveness MK0916 patient Type 2 Diabetes Mellitus Metabolic Syndrome . This early phase trial specific protocol information progress publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>MK0916 Patients With Type 2 Diabetes Metabolic Syndrome ( 0916-005 )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Have Type 2 Diabetes 18 65 year age History Type 1 Diabetes Mellitus Have treat insulin past 8 week On weight loss program ongoing weight loss Taking weight loss medication Have surgery require general anesthesia past 30 day plan surgery Have take another investigational drug last 8 week Have active liver disease Have history major surgery involve gastric intestinal bypass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>